You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 1476 to 1500 of about 5880
Next 25
04/18/2017
FDA Okays Clinical Trial of Injectable Brain Cancer Drug - See more at: https://www.specialtypharmacytimes.com/news/fda-okays-clinical-trial-of-injectable-brain-cancer-drug
04/17/2017
CNS Oncology Publishes Data Suggesting Survival Benefit of Optune™ in Combination with Second Line Chemotherapies after Glioblastoma Recurrence
Survey on the use of animals in brain cancer research
04/14/2017
Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination
Medicenna Treats First Patient in Phase 2b Recurrent Glioblastoma Trial
04/12/2017
Feinstein Institute examines use of antiparasitic drug as new treatment for brain tumors
04/09/2017
DFFN: Phase 3 Trial of TSC in GBM to Initiate in 2017
04/07/2017
A Proposed New FDA Drug Approval Pathway: “Conditional Approval”
04/06/2017
Retroviral replicating vector–mediated gene therapy achieves long-term control of tumor recurrence and leads to durable anticancer immunity
Tocagen wins "Most Successful Early Phase Trial" and "Excellence in Rare Disease Drug Development" awards!
Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG.
04/05/2017
Bristol-Myers’ checkpoint star Opdivo fails a PhIII study for glioblastoma
DelMar Pharmaceuticals Provides VAL-083 Updates from the Ongoing American Association for Cancer Research (AACR) Annual Meeting
04/03/2017
"Sci-fi" cancer therapy fights brain tumors, study finds
03/29/2017
MGH/Dana Farber Initiate Expansion of ONC201 Glioblastoma Trial
03/21/2017
VBI Vaccines Building On Duke University Research for New Cancer Therapy
03/20/2017
Is it time for "Conditional Approvals"?
03/17/2017
Antibody treats pediatric brain tumors safely and effectively in mice
Medicenna BioPharma Announces Strategic Collaboration with MD Anderson Cancer Center to Advance Next Generation Empowered Cytokines™
Limited role for extended maintenance temozolomide for newly diagnosed glioblastoma.
03/10/2017
Role of MGMT Methylation Status at Time of Diagnosis and Recurrence for Patients with Glioblastoma: Clinical Implications.
4th ANNUAL HOOPS FOR HANNAH FUNDRAISER FOR BRAIN TUMOR RESEARCH
Ependymoma Awareness Day.
Clinical Trial Announcement Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Glioblastoma at First Recurrence or Progression
Trump Chooses Dr. Scott Gottlieb To Head Food And Drug Administration